Lung Cancer - Page 11

October 27, 2016

Cancer survivors take more psych meds than other people

People who live through a bout with cancer are more likely to use medication for anxiety and depression than those without a history of malignancies, a U.S. study suggests.

October 26, 2016

The secondhand smoke you don't even know you're exposed to is killing you

Individuals who are unaware that they’re being exposed to secondhand smoke may face a higher risk of death from cancer and other smoking-related disease, according to a study from the Icahn School of Medicine at Mount Sinai.

October 25, 2016

Changes in depression symptoms tied to lung cancer survival

Worsening depression symptoms are associated with shorter survival for lung cancer patients, particularly those in the early stages of disease, according to a new U.S. study.

October 25, 2016

E-cigarettes could be used to help combat obesity in smokers trying to quit: study

Researchers in Britain and New Zealand have found a potential new use for electronic cigarettes in smokers who want to give up - controlling appetite and limiting the weight gain that often comes with quitting.

October 25, 2016

FDA approves Merck's lung cancer drug as first-line treatment

Merck & Co Inc on Monday said the U.S. Food and Drug Administration has approved its immunotherapy Keytruda for use in certain previously untreated lung cancer patients, making it the only approved first-line treatment.

October 24, 2016

Secondhand smoke linked to higher risk of stroke

The increased risk of stroke that comes with smoking may extend to nonsmokers who live in the same household and breathe in secondhand smoke, a U.S. study suggests.

October 20, 2016

Roche's lung cancer drug wins US approval

Swiss drugmaker Roche Holding AG's new immunotherapy, Tecentriq, won approval on Tuesday from U.S. health regulators as a second-line lung cancer treatment, a decision seen likely to erode Bristol-Myers Squibb's position in this hotly contested market.

October 20, 2016

Doctors grapple with best use of potent new cancer drugs

Evelyn O'Flynn still has lung cancer.

October 10, 2016

'New day' in lung cancer as Merck drug shines, works with chemo

Merck & Co scored a double hit on Sunday with new clinical data showing its Keytruda immunotherapy offered big benefits in previously untreated lung cancer patients, either when given on its own or with chemotherapy.

October 5, 2016

Toxins remain in homes for months after smokers quit

A home's air may seem cleaner after a smoker has quit, but researchers report in the journal Tobacco Control that toxins from tobacco smoke can linger for months.